Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$631,982,729
-$148,227,594 QoQ
Shares Held
1,013,540
+0.4% QoQ
Ownership
0.984%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#19
of 1,322 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. REGN ranks #2 (26.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $631,982,729 | 1,013,540 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $780,210,323 | 1,009,798 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $611,248,482 | 791,906 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $349,586,310 | 621,741 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $470,993,775 | 897,131 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,017,242,120 | 1,603,901 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,105,347,380 | 1,551,735 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,118,777,952 | 1,064,246 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,118,630,137 | 1,064,318 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,016,831,212 | 1,056,459 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $802,866,837 | 914,125 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $563,962,957 | 685,286 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $491,992,950 | 684,712 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $634,505,889 | 772,215 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $501,749,390 | 695,435 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $451,340,730 | 655,190 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $327,786,304 | 554,508 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $348,462,683 | 498,930 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $290,707,594 | 460,330 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $258,083,244 | 426,457 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $112,500,560 | 201,419 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||